Quantcast

Latest Cell biology Stories

2014-06-09 10:48:48

Brookhaven National Laboratory Structure of membrane protein that plays a role in signaling cell death could be new target for anticancer drugs Sometimes a cell has to die—when it's done with its job or inflicted with injury that could otherwise harm an organism. Conversely, cells that refuse to die when expected can lead to cancer. So scientists interested in fighting cancer have been keenly interested in learning the details of "programmed cell death." They want to understand what...

2014-06-08 23:00:09

A number of factors such as increasing funding from various government and private organizations, growing industry focus on stem cell research, and rising global awareness about stem cell therapies through various organizations are driving the growth of the global market. http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html (PRWEB) June 09, 2014 The report “Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic...

2014-06-05 13:21:24

VIB (the Flanders Institute for Biotechnology) Researchers at VIB and Ghent University have unraveled the mechanism of necroptosis. This is a type of cell death that plays a crucial role in numerous diseases, from viral infections and loss of auditory nerve cells to multiple sclerosis, acute heart failure and organ transplantation. Having detailed knowledge of the cell death process enables a targeted search for new drugs. Peter Vandenabeele (VIB/UGent): "The molecular mechanism of...

2014-06-05 12:31:31

FARMINGTON, Conn., June 5, 2014 /PRNewswire/ -- ImStem Biotechnology, Inc. (ImStem) announced today it has successfully treated an animal model of multiple sclerosis (MS) using human embryonic stem cells (hESC) derived mesenchymal stem cells (MSCs), called hES-MSCs. Photo - http://photos.prnewswire.com/prnh/20140605/94816Photo - http://photos.prnewswire.com/prnh/20140605/94808 MS is a chronic neuroinflammatory disease with no cure. Most current MS therapies offer only palliative...

Scientists Successfully Transplant And Grow Stem Cells In Pigs
2014-06-05 03:38:48

Nathan Hurst, University of Missouri One of the biggest challenges for medical researchers studying the effectiveness of stem cell therapies is that transplants or grafts of cells are often rejected by the hosts. This rejection can render experiments useless, making research into potentially life-saving treatments a long and difficult process. Now, researchers at the University of Missouri have shown that a new line of genetically modified pigs will host transplanted cells without the...

2014-06-04 08:26:06

Renowned health writer documents discovery of modified citrus pectin in her latest book SANTA ROSA, Calif., June 4, 2014 /PRNewswire/ -- One of the nation's leading writers on the use of naturopathic medicine has released a new book documenting groundbreaking studies on modified citrus pectin (MCP) and its application for addressing serious health issues like cancer, heart disease, chronic inflammation and fibrosis. The book, New Twist on Health: Modified Citrus Pectin for Cancer,...

2014-06-03 23:03:26

Regulating Biosimilars; Stem Cell Therapies and 3-D Printing; Increasing FDA Oversight Overseas Washington (PRWEB) June 03, 2014 Hot topics facing drug development and access—evolving regulatory guidelines for novel therapies, a shifting pharmaceutical research and development (R&D) landscape, and U.S. regulatory challenges at home and overseas—will be discussed by global innovators at the DIA 2014 50th Annual Meeting, to be held at the San Diego Convention Center from June 15 to...

2014-06-03 23:02:06

On June 3, at the 7th Annual Massachusetts Life Sciences Innovation Day, Dr. James L. Sherley, Director of The Adult Stem Cell Technology Center, LLC presented a new technology developed to identify drug candidates that are toxic to adult stem cells. This first technology of its kind meets a long-standing unmet need of the pharmaceutical industry, with potential to save billions of dollars in drug development costs each year while accelerating the arrival of new effective, and safe, drugs...

2014-06-03 12:38:22

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biobanking for Medicine: Technology, Industry and Market 2014-2024http://www.reportbuyer.com/pharma_healthcare/biotechnology/biobanking_medicine_technology_market.html Report DetailsBiobanks - how to find business trends, R&D, and revenue forecastsWhat does the future hold for medical biobanks? Now you get technological and commercial predictions from 2014. Stay ahead, then, for data,...

2014-06-03 12:37:18

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Translational Regenerative Medicine: Market Prospects 2014-2024http://www.reportbuyer.com/pharma_healthcare/research_r_d/translational_regenerative_medicine_market_prospects_2012_2022.html Report DetailsOur new study shows you the commercial potential of regenerative treatmentsWhat does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to...


Latest Cell biology Reference Libraries

Paneth Cells
2012-07-01 19:03:07

Paneth Cells are one of four principal cell types found in the epithelium of the small intestine; the other three are the goblet cell, enterocyte, and enteroendocrine cell. Paneth cells may also be found in the cecum and appendix, although sporadically. These cells are identifiable microscopically by their location just below the intestinal stem cells in the intestinal glands. and the large eosinophilic refractile granules that occupy most of their cytoplasm. These granules consist of...

Cell (journal)
2012-06-04 14:15:36

Cell is a peer-reviewed scientific journal founded by Benjamin Lewin in January 1974 with the sponsorship of MIT Press. Lewin bought the rights to the journal in 1986 and published it under his own publishing arm Cell Press. Cell Press was sold to Elsevier in 1999, which currently publishes Cell twice monthly. Cell Press publishes several biomedical journals, including Cell, Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry &...

72_cefd267015c8eb1fc075a3a404bc6033
2011-04-15 15:02:18

Francisella tularensis is a pathogenic species of gram-negative bacteria and the causative agent of tularemia or rabbit fever. It is a facultative intracellular bacterium. It is classified as a Class A agent by the U.S. government due to its ease of spread by aerosol and its high virulence. In 1911 the species was found in ground squirrels in California. There are four subspecies that have been classified. Biovar tularensis is found mostly in North America. Biovar palearctica is found...

More Articles (3 articles) »
Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related